Difference between revisions of "User:Jwarner"
m (Added picture) Tag: visualeditor |
m (CTO) |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | Jeremy L. Warner MD, MS | + | [[File:Warner,_Jeremy_MD_2022.jpg|thumb|Jeremy L. Warner MD, MS, FAMIA, FASCO]] |
| − | [[ | + | Jeremy L. Warner MD, MS, FAMIA, FASCO was an [http://www.vicc.org/dd/display.php?person=jeremy.warner Associate Professor of Medicine and Biomedical Informatics at Vanderbilt University] until June 2022, when he joined Lifespan Cancer Institute and Brown University. He is a Professor of Medicine and the Director of the Center for Clinical Cancer Informatics and Data Science at Brown/Lifespan. He is the Deputy Editor of the ASCO journal [http://cci.jco.org/ ''JCO Clinical Cancer Informatics'']. His clinical area is malignant hematology with a focus on the lymphoid malignancies. His research interests involve the use of informatics for clinical and research endeavors, including the standardization of chemotherapy regimen information with an ultimate goal of enabling interoperability and discovering better cancer treatment options. A list of his publications can be found on [https://scholar.google.com/citations?user=k_9sF90AAAAJ&hl=en Google Scholar]. |
| − | + | He is the Chief Technology Officer of HemOnc.org and Chief Software Architect of the [[Ontology|HemOnc Ontology]]. | |
Latest revision as of 20:16, 25 April 2024
Jeremy L. Warner MD, MS, FAMIA, FASCO was an Associate Professor of Medicine and Biomedical Informatics at Vanderbilt University until June 2022, when he joined Lifespan Cancer Institute and Brown University. He is a Professor of Medicine and the Director of the Center for Clinical Cancer Informatics and Data Science at Brown/Lifespan. He is the Deputy Editor of the ASCO journal JCO Clinical Cancer Informatics. His clinical area is malignant hematology with a focus on the lymphoid malignancies. His research interests involve the use of informatics for clinical and research endeavors, including the standardization of chemotherapy regimen information with an ultimate goal of enabling interoperability and discovering better cancer treatment options. A list of his publications can be found on Google Scholar.
He is the Chief Technology Officer of HemOnc.org and Chief Software Architect of the HemOnc Ontology.